SIGA Technologies Inc SIGA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.31
- Day Range
- $4.30–4.36
- 52-Week Range
- $4.10–9.62
- Bid/Ask
- $4.30 / $4.71
- Shares Outstanding
- 71.72M
- Market Cap
- $309.85M
- Volume/Avg
- 226,562 / 616,485
Key Statistics
- Price/Earnings (Normalized)
- 15.39
- Price/Sales
- 3.31
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 49
- Website
- https://www.siga.com
Valuation
|
Metric
|
SIGA
|
|---|---|
Price/Earnings (Normalized) | 15.39 |
Price/Book Value | 2.04 |
Price/Sales | 3.31 |
Price/Cash Flow | 9.79 |
Price/Earnings
SIGA
Financial Strength
|
Metric
|
SIGA
|
|---|---|
Quick Ratio | 2.30 |
Current Ratio | 3.25 |
Interest Coverage | — |
Quick Ratio
SIGA
Profitability
|
Metric
|
SIGA
|
|---|---|
Return on Assets (Normalized) | 9.93% |
Return on Equity (Normalized) | 11.69% |
Return on Invested Capital (Normalized) | 11.65% |
Return on Assets
SIGA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Hgmnpxrjv | Hnlcdls | $67B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Sqdrmyzgf | Fkdxxyc | $40B | |||
| Haleon PLC ADR
HLN
| Stngnllm | Yxhvm | $40B | |||
| Zoetis Inc Class A
ZTS
| Sbtvtklnw | Tts | $33B | |||
| Viatris Inc
VTRS
| Gmgflrkhy | Mqybw | $19B | |||
| Elanco Animal Health Inc
ELAN
| Mqbhb | Zlhz | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Rklmgkhy | Qbyyh | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| Rttqmsjz | Zkytl | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| Dtxyryv | Dbksyn | $2B | |||
| Perrigo Co PLC
PRGO
| Tljttzkv | Mgnk | $2B |
United States